Funding Rounds
Reapplix

Reapplix Unknown (2019, $3M)

Reapplix

Technology that identifies blood-derived proteins to enhance wound healing for patients with chronic wounds.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Unknown

Raised Amount: $3.70M

Raised Date: 2019-01-01

Investors